Renal biomarkers encompass proteins, lipids, genes, metabolites, proteomic patterns, or cells that are identified through urinalysis to assess the glomerular filtration rate of the kidney. A decrease in this rate is indicative of kidney damage, and renal biomarkers are instrumental in estimating the nature and severity of such injuries.
The main types of biomarkers in renal biomarker analysis include functional biomarkers, upregulated proteins, and other biomarker categories. Functional biomarkers are particularly significant as they allow the diagnosis of kidney injury in individuals with normal kidney function and in chronic kidney disease patients where the same injury would result in a substantial decrease in functional biomarkers like creatinine (Cr). Various diagnostic techniques, such as enzyme-linked immunosorbent assay, particle-enhanced turbidimetric immunoassay (PETIA), colorimetric assay, chemiluminescent enzyme immunoassay (CLIA), and liquid chromatography-mass spectrometry (LC-MS), are employed for renal biomarker analysis. These biomarkers find applications in diagnosis, disease progression monitoring, and research, and they are utilized by hospitals, diagnostic laboratories, and other end-users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The renal biomarker market research report is one of a series of new reports from The Business Research Company that provides renal biomarker market statistics, including renal biomarker industry global market size, regional shares, competitors with a renal biomarker market share, detailed renal biomarker market segments, market trends and opportunities, and any further data you may need to thrive in the renal biomarker industry. This renal biomarker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The renal biomarkers market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing prevalence of kidney diseases, advances in medical diagnostics, aging population, growing awareness of early disease detection, adoption of point-of-care testing, rise in chronic diseases.
The renal biomarkers market size is expected to see strong growth in the next few years. It will grow to $1.9 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to personalized medicine and targetedTherapies, integration of biomarker testing into routine clinical practice, emerging markets in asia and latin america, non-invasive biomarker testing methods, continuous monitoring with wearable devices. Major trends in the forecast period include multiplex biomarker panels for comprehensive disease profiling, ai and machine learning for biomarker discovery, biomarker-based companion diagnostics, poc biomarker testing in home healthcare settings, biomarkers for early detection and prevention.
The forecast of 8.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. nephrology practices by increasing the cost of NGAL and cystatin C assay kits sourced from Sweden and Belgium, thereby delaying early kidney injury detection and elevating diagnostic testing expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increase in geriatric and pediatric renal patients is expected to drive the growth of the renal biomarkers market in the coming years. Geriatric renal patients refer to elderly individuals over the age of 70 with advanced chronic kidney disease (CKD), while pediatric renal patients are those diagnosed with renal disorders during childhood and young adulthood. Renal biomarkers are essential for assessing the severity of kidney injury in both geriatric and pediatric patients. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency, reported that chronic kidney disease (CKD) mortality rates rose by 4.2% in 2021 and 6.2% in 2022. Thus, the increasing number of geriatric and pediatric renal patients is contributing to the growth of the renal biomarkers market.
The increasing incidence of chronic kidney diseases is expected to drive the growth of the renal biomarkers market in the future. Chronic kidney disease (CKD) is a condition marked by the gradual decline in kidney function over time. Renal biomarkers are essential for detecting and monitoring the progression of CKD, enabling timely interventions and personalized treatment strategies, which lead to better patient outcomes. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency, reported that CKD mortality rates rose by 4.2% in 2021 and 6.2% in 2022. As a result, the growing prevalence of chronic kidney diseases is fueling the expansion of the renal biomarkers market.
Technological advancements have become a key trend gaining traction in the renal biomarkers market. Leading companies in the sector are focusing on developing innovative technologies to maintain their market position. For example, in March 2022, Nipro Medical Corporation, a US-based medical equipment manufacturer, introduced the SURDIAL DX. This advanced hemodialysis system incorporates cutting-edge technology to ensure optimal patient safety, comfort, and efficiency. It features modern design elements such as streamlined automated processes, ergonomic design, and a focus on improving the overall dialysis treatment experience.
Strategic collaborations and partnerships with start-ups and mid-sized companies are becoming increasingly prevalent in the renal biomarkers market. This approach allows major companies to expand their product and service offerings. In June 2022, Nordic Bioscience, a Denmark-based biomarker company, strengthened its collaboration with F. Hoffmann-La Roche Ltd., a multinational healthcare company. This collaboration involves the development of proprietary biomarkers related to tissue breakdown and build-up. Nordic Bioscience's ECM biomarkers are deemed essential for various chronic diseases, including kidney diseases. The partnership aims to improve clinical decisions in drug development and patient selection, ultimately enhancing patient outcomes.
In January 2024, Novartis AG, a Switzerland-based pharmaceutical company, acquired SanReno Therapeutics for an undisclosed amount. This rare acquisition of a Chinese biotech firm by a multinational company underscores China's potential in the global renal market and aligns with Novartis' commitment to innovative therapies for kidney diseases. SanReno Therapeutics is a China-based biopharmaceutical company that specializes in renal disease therapies.
Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMerieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.
North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the renal biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The renal biomarker market consists of revenues earned by entities by providing renal biomarker services such as integrated drug discovery, phenotypic assay, custom services, in vivo, biomarker identification, glomerular filtration diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The renal biomarker market also includes sales of point-of-care kit, antibody screening, cell-based diagnostic devices which are used in providing renal biomarker services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Renal Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on renal biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for renal biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The renal biomarkers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Biomarker Type: Functional Biomarker; Up Regulated Protein; Other Biomarker Types
- 2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay; Particle-Enhanced Turbidimetric Immunoassay (PETIA); Colorimetric Assay; Chemiluminescent Enzyme Immunoassay (CLIA); Liquid Chromatography Mass Spectrometry (LS-MS)
- 3) By Application: Diagnosis And Disease Progression Monitoring; Research Homecare
- 4) By End User: Hospitals; Diagnostic Laboratories; Other End Users
- Subsegments:
- 1) By Functional Biomarker: Creatinine; Urea; Cystatin C; Bicarbonate
- 2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL); Kidney Injury Molecule-1 (KIM-1); Interleukin-18 (IL-18)
- 3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers; Acute Kidney Injury Biomarkers; Chronic Kidney Disease Biomarkers
- Companies Mentioned: Abbott Laboratories; BioPorto Diagnostics A/S; Roche Holding AG; Thermo Fisher Scientific; bioMerieux SA; Randox Laboratories; Siemens Healthineers; Beckman Coulter Inc.; Astute Medical Inc.; Nexelis Company; Sphingotec GmbH; Bio-Rad Laboratories India Pvt. Ltd.; Enzo Biochem Inc.; PerkinElmer Inc.; Novartis AG; Alere Inc.; AstraZeneca plc; Bio-Techne Corp.; DiaSorin S.p.A.; EKF Diagnostics Holdings plc; Fujirebio Diagnostics Inc.; Gold Standard Diagnostics Corp.; Merck KGaA; Myriad RBM Inc.; Ortho Clinical Diagnostics Holdings plc; Quidel Corporation; R&D Systems Inc.; Roche Diagnostics International Ltd.; Sekisui Chemical Co. Ltd.; Sysmex Corporation; Tosoh Bioscience Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Renal Biomarkers Market Characteristics
3. Renal Biomarkers Market Trends And Strategies
4. Renal Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Renal Biomarkers Growth Analysis And Strategic Analysis Framework
- 5.1. Global Renal Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Renal Biomarkers Market Growth Rate Analysis
- 5.4. Global Renal Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Renal Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Renal Biomarkers Total Addressable Market (TAM)
6. Renal Biomarkers Market Segmentation
- 6.1. Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Functional Biomarker
- Up Regulated Protein
- Other Biomarker Types
- 6.2. Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Enzyme-Linked Immunosorbent Assay
- Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- Colorimetric Assay
- Chemiluminescent Enzyme Immunoassay (CLIA)
- Liquid Chromatography Mass Spectrometry (LS-MS)
- 6.3. Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnosis And Disease Progression Monitoring
- Research Homecare
- 6.4. Global Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Laboratories
- Other End Users
- 6.5. Global Renal Biomarkers Market, Sub-Segmentation Of Functional Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Creatinine
- Urea
- Cystatin C
- Bicarbonate
- 6.6. Global Renal Biomarkers Market, Sub-Segmentation Of Up Regulated Protein, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neutrophil Gelatinase-Associated Lipocalin (NGAL)
- Kidney Injury Molecule-1 (KIM-1)
- Interleukin-18 (IL-18)
- 6.7. Global Renal Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Proximal Tubule Injury Biomarkers
- Acute Kidney Injury Biomarkers
- Chronic Kidney Disease Biomarkers
7. Renal Biomarkers Market Regional And Country Analysis
- 7.1. Global Renal Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Renal Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Renal Biomarkers Market
- 8.1. Asia-Pacific Renal Biomarkers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Renal Biomarkers Market
- 9.1. China Renal Biomarkers Market Overview
- 9.2. China Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Renal Biomarkers Market
- 10.1. India Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Renal Biomarkers Market
- 11.1. Japan Renal Biomarkers Market Overview
- 11.2. Japan Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Renal Biomarkers Market
- 12.1. Australia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Renal Biomarkers Market
- 13.1. Indonesia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Renal Biomarkers Market
- 14.1. South Korea Renal Biomarkers Market Overview
- 14.2. South Korea Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Renal Biomarkers Market
- 15.1. Western Europe Renal Biomarkers Market Overview
- 15.2. Western Europe Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Renal Biomarkers Market
- 16.1. UK Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Renal Biomarkers Market
- 17.1. Germany Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Renal Biomarkers Market
- 18.1. France Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Renal Biomarkers Market
- 19.1. Italy Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Renal Biomarkers Market
- 20.1. Spain Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Renal Biomarkers Market
- 21.1. Eastern Europe Renal Biomarkers Market Overview
- 21.2. Eastern Europe Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Renal Biomarkers Market
- 22.1. Russia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Renal Biomarkers Market
- 23.1. North America Renal Biomarkers Market Overview
- 23.2. North America Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Renal Biomarkers Market
- 24.1. USA Renal Biomarkers Market Overview
- 24.2. USA Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Renal Biomarkers Market
- 25.1. Canada Renal Biomarkers Market Overview
- 25.2. Canada Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Renal Biomarkers Market
- 26.1. South America Renal Biomarkers Market Overview
- 26.2. South America Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Renal Biomarkers Market
- 27.1. Brazil Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Renal Biomarkers Market
- 28.1. Middle East Renal Biomarkers Market Overview
- 28.2. Middle East Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Renal Biomarkers Market
- 29.1. Africa Renal Biomarkers Market Overview
- 29.2. Africa Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Renal Biomarkers Market Competitive Landscape And Company Profiles
- 30.1. Renal Biomarkers Market Competitive Landscape
- 30.2. Renal Biomarkers Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BioPorto Diagnostics A/S Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
31. Renal Biomarkers Market Other Major And Innovative Companies
- 31.1. Randox Laboratories
- 31.2. Siemens Healthineers
- 31.3. Beckman Coulter Inc.
- 31.4. Astute Medical Inc.
- 31.5. Nexelis Company
- 31.6. Sphingotec GmbH
- 31.7. Bio-Rad Laboratories India Pvt. Ltd.
- 31.8. Enzo Biochem Inc.
- 31.9. PerkinElmer Inc.
- 31.10. Novartis AG
- 31.11. Alere Inc.
- 31.12. AstraZeneca plc
- 31.13. Bio-Techne Corp.
- 31.14. DiaSorin S.p.A.
- 31.15. EKF Diagnostics Holdings plc
32. Global Renal Biomarkers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Renal Biomarkers Market
34. Recent Developments In The Renal Biomarkers Market
35. Renal Biomarkers Market High Potential Countries, Segments and Strategies
- 35.1 Renal Biomarkers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Renal Biomarkers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Renal Biomarkers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
